Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review

Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review

Detalles Bibliográficos
Main Authors:	Knight, S, Morris, P
Formato:	Journal article
Idioma:	English
Publicado:	2008

Títulos similares

Mycophenolate mofetil and atherosclerosis
por: Z S Alekberova, et al.
Publicado: (2009-10-01)

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of pediatric lupus nephritis: A cross-sectional study
por: Navamani Kirubakaran, et al.
Publicado: (2022-01-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
por: Tomoko Mizaki, et al.
Publicado: (2023-01-01)

Mycophenolate Mofetil-Induced Pneumatosis Intestinalis
por: Daphne Moutsoglou, et al.
Publicado: (2024-01-01)

Mycophenolate mofetil in giant cell arteritis
por: Anne Pankow, et al.
Publicado: (2023-11-01)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Patrick FK Yong, et al.
Publicado: (2008-06-01)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
por: Lan-Fang Li, et al.
Publicado: (2023-03-01)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil induced gastrointestinal disorders
por: Sanaz Sheikhzadeh, et al.
Publicado: (2013-06-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
por: L P Ananyeva
Publicado: (2009-03-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
por: A. I. Dolgushina, et al.
Publicado: (2021-12-01)

Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
por: Joyce J. Kim, et al.
Publicado: (2020-01-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
por: Rebecca M. Yim, et al.
Publicado: (2023-03-01)

Management of erythema nodosum leprosum by mycophenolate mofetil
por: Banerjee Kalyan, et al.
Publicado: (2008-01-01)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
por: Seung Woon Park, et al.
Publicado: (2016-06-01)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
por: Xuebing Zhang, et al.
Publicado: (2020-11-01)

Off-lable uses of mycophenolate mofetil: lupus nephritis
por: B. Fernández-García, et al.
Publicado: (2015-07-01)

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Argyris Tzouvelekis, et al.
Publicado: (2011-01-01)

Mycophenolate mofetil induced transfusion dependent anemia in lupus
por: Anand Prahalad Rao, et al.
Publicado: (2018-01-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
por: Božić-Majstorović Ljubinka, et al.
Publicado: (2024-01-01)

Mycophenolate mofetil for the treatment of autoimmune diseases: hype or hope?
por: Swiss Medical Weekly
Publicado: (2009-01-01)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
por: A. Hackl, et al.
Publicado: (2023-08-01)

Mycophenolate mofetil (CellCept) in patients with autoimmune hepatitis
por: Abdo Ayman
Publicado: (2006-01-01)

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
por: Martini G, et al.
Publicado: (2008-09-01)

Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis.
por: Anoop M Nambiar, et al.
Publicado: (2017-01-01)

Recalcitrant lymphocytoma cutis successfully treated with mycophenolate mofetil
por: Farhan Mahmood, et al.
Publicado: (2021-06-01)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Stephanie Del Rio Navarrete Biot, et al.
Publicado: (2014-12-01)

Therapeutic efficacy and clinical effectiveness of mycophenolate mofetil and dexamethasone for immune thrombocytopenia: A retrospective observational study
por: Nilesh Wasekar, et al.
Publicado: (2021-01-01)

Mycophenolate Mofetil as a Potential Therapeutic Option for Neuropsychiatric Lupus: A Case Report
por: Warren Weng Seng Fong MBBS, MRCP, et al.
Publicado: (2014-12-01)

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Kyle M. Gardiner, et al.
Publicado: (2018-11-01)

Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.
por: Knight, SR, et al.
Publicado: (2009)

In vitro mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and others
por: Junjun Mao, et al.
Publicado: (2024-08-01)

Favorable long-term outcomes of autoimmune nodopathy with mycophenolate mofetil
por: Young Gi Min, et al.
Publicado: (2024-12-01)

Esophageal Cicatricial Pemphigoid as an Isolated Involvement Treated with Mycophenolate Mofetil
por: Sandra Sánchez Prudencio, et al.
Publicado: (2015-01-01)

Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil
por: Anabela Malho, et al.
Publicado: (2010-01-01)

Acquired Perforating Dermatosis: A Disorder Treatable with Mycophenolate Mofetil
por: Shaima Al-Bader, et al.
Publicado: (2023-12-01)

Management of pemphigoid vegetans with mycophenolate mofetil: A case report
por: Audrey Mathieu, et al.
Publicado: (2024-02-01)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
por: Kelly Z. Young, BA, et al.
Publicado: (2022-10-01)

Post COVID‐19 organizing pneumonia treated with mycophenolate mofetil
por: Hui Xin Tan, et al.
Publicado: (2022-11-01)

"TREATMENT OF CHRONIC PLAQUE TYPE PSORIASIS WITH SYSTEMIC MYCOPHENOLATE MOFETIL "
por: S. Toosi R. M. Robati, et al.
Publicado: (2006-11-01)

Treatment of severe henoch-schonlein purpura nephritis with mycophenolate mofetil
por: Ahmad Ali Nikibakhsh, et al.
Publicado: (2014-01-01)